Gilenya and PML – A New Concern
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The MultipleSclerosis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod) Available at: http://www.fda.gov/Drugs/DrugSafety/ucm366529.htm Accessed August 2013
- Gever, J. PML Case Seen in Patient on Gilenya. Available at: http://www.medpagetoday.com/Neurology/MultipleSclerosis/40748 Accessed August 2013